The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(2,4-Dichloro-3-(2-cyclopropyl-5-methyl-4-(1-(trifluoromethyl)cyclopropyl)-1H-imidazole-1-yl)phenyl)-2-azaspiro[3.3]heptane-6-carboxylic Acid ID: ALA4513808
PubChem CID: 155539171
Max Phase: Preclinical
Molecular Formula: C24H24Cl2F3N3O2
Molecular Weight: 514.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C2(C(F)(F)F)CC2)nc(C2CC2)n1-c1c(Cl)ccc(N2CC3(CC(C(=O)O)C3)C2)c1Cl
Standard InChI: InChI=1S/C24H24Cl2F3N3O2/c1-12-19(23(6-7-23)24(27,28)29)30-20(13-2-3-13)32(12)18-15(25)4-5-16(17(18)26)31-10-22(11-31)8-14(9-22)21(33)34/h4-5,13-14H,2-3,6-11H2,1H3,(H,33,34)
Standard InChI Key: ATOAVZQFLCOJQE-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 39 0 0 0 0 0 0 0 0999 V2000
29.2152 -21.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4152 -20.8324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1986 -21.6323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9986 -21.8490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2000 -19.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2042 -20.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9165 -20.3172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0710 -20.4583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3565 -20.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3618 -19.2197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6481 -18.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9327 -19.2199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9353 -20.0492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6495 -20.4578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0777 -18.8096 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.1618 -21.2780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9688 -21.4495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3813 -20.7350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8292 -20.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9291 -20.8625 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.0012 -19.3152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2223 -20.4642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6181 -21.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4431 -21.4452 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.2071 -22.1623 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.0250 -22.1583 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.5511 -21.8345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7446 -22.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2984 -22.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4269 -20.2523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0139 -21.2606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4830 -22.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7696 -21.6285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4808 -22.8679 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
6 5 1 0
7 6 1 0
5 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
10 15 1 0
8 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 8 1 0
14 20 1 0
19 21 1 0
18 6 1 0
13 22 1 0
6 23 1 0
23 24 1 0
23 25 1 0
23 26 1 0
28 27 1 0
29 28 1 0
27 29 1 0
16 27 1 0
22 30 1 0
30 1 1 0
1 31 1 0
31 22 1 0
3 32 1 0
32 33 1 0
32 34 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.38Molecular Weight (Monoisotopic): 513.1198AlogP: 6.26#Rotatable Bonds: 5Polar Surface Area: 58.36Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 4.08CX Basic pKa: 6.12CX LogP: 4.44CX LogD: 3.25Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.51Np Likeness Score: -0.42
References 1. Hoegenauer K, Kallen J, Jiménez-Núñez E, Strang R, Ertl P, Cooke NG, Hintermann S, Voegtle M, Betschart C, McKay DJJ, Wagner J, Ottl J, Beerli C, Billich A, Dawson J, Kaupmann K, Streiff M, Gobeau N, Harlfinger S, Stringer R, Guntermann C.. (2019) Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors., 62 (23): [PMID:31729873 ] [10.1021/acs.jmedchem.9b01291 ]